Oscar Suzuki

1.2k total citations
25 papers, 817 citations indexed

About

Oscar Suzuki is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Oscar Suzuki has authored 25 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Genetics. Recurrent topics in Oscar Suzuki's work include Cell Adhesion Molecules Research (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Calpain Protease Function and Regulation (2 papers). Oscar Suzuki is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Calpain Protease Function and Regulation (2 papers). Oscar Suzuki collaborates with scholars based in United States, Brazil and Italy. Oscar Suzuki's co-authors include Maria Rita Passos‐Bueno, Tim Wiltshire, Eloísa S. Moreira, Mayana Zatz, Mariz Vainzof, Georgine Faulkner, Giorgio Valle, Dieter E. Jenne, Roger H. Reeves and Andréa L. Sertié and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Oscar Suzuki

25 papers receiving 795 citations

Peers

Oscar Suzuki
Tang Zhu Canada
Michael Broman United States
Robert Pick Germany
Britt Johnson United States
Tang Zhu Canada
Oscar Suzuki
Citations per year, relative to Oscar Suzuki Oscar Suzuki (= 1×) peers Tang Zhu

Countries citing papers authored by Oscar Suzuki

Since Specialization
Citations

This map shows the geographic impact of Oscar Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar Suzuki more than expected).

Fields of papers citing papers by Oscar Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar Suzuki. The network helps show where Oscar Suzuki may publish in the future.

Co-authorship network of co-authors of Oscar Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar Suzuki. A scholar is included among the top collaborators of Oscar Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar Suzuki. Oscar Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Amy, Oscar Suzuki, Akinyemi Oni‐Orisan, et al.. (2018). Projected Impact of a Multigene Pharmacogenetic Test to Optimize Medication Prescribing in Cardiovascular Patients. Pharmacogenomics. 19(9). 771–782. 15 indexed citations
2.
Suzuki, Oscar, et al.. (2018). Implementing Clinical Pharmacogenomics in the Classroom: Student Pharmacist Impressions of an Educational Intervention Including Personal Genotyping. SHILAP Revista de lepidopterología. 6(4). 115–115. 18 indexed citations
3.
Chen, Jingxian, Farida S. Akhtari, Michael J. Wagner, et al.. (2017). Pharmacogenetic Analysis of the Model‐Based Pharmacokinetics of Five Anti‐HIV Drugs: How Does This Influence the Effect of Aging?. Clinical and Translational Science. 11(2). 226–236. 7 indexed citations
4.
Song, Gina, Oscar Suzuki, Charlene Santos, et al.. (2016). Gulp1 is associated with the pharmacokinetics of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains. Nanomedicine Nanotechnology Biology and Medicine. 12(7). 2007–2017. 10 indexed citations
5.
Scolaro, Kelly L., et al.. (2016). Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists. Frontiers in Pharmacology. 7. 241–241. 26 indexed citations
6.
Fedoriw, Yuri, Kristy L. Richards, Blossom Damania, et al.. (2015). Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics. Pharmacogenomics and Personalized Medicine. 8. 81–81. 11 indexed citations
7.
Suzuki, Oscar, et al.. (2015). Identifying genes that mediate anthracyline toxicity in immune cells. Frontiers in Pharmacology. 6. 62–62. 3 indexed citations
8.
Suzuki, Oscar, O. Joseph Trask, Natasha Butz, et al.. (2014). A cellular genetics approach identifies gene-drug interactions and pinpoints drug toxicity pathway nodes. Frontiers in Genetics. 5. 272–272. 4 indexed citations
9.
Suzuki, Oscar, et al.. (2013). In Vitro and In Vivo Mouse Models for Pharmacogenetic Studies. Methods in molecular biology. 1015. 263–278. 6 indexed citations
10.
Miller, Brooke H., Oscar Suzuki, Michael D. Cameron, et al.. (2011). Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology. 221(2). 297–315. 41 indexed citations
11.
Suzuki, Oscar, Hideki Ishii, & S Kobayashi. (2011). Effects of an Angiotensin 2 Receptor Blocker plus Diuretic Combination Drug in Chronic Heart Failure Complicated by Hypertension. Journal of International Medical Research. 39(4). 1420–1426. 4 indexed citations
12.
Bopp, Selina, Kerstin Henson, Brian Steffy, et al.. (2010). Genome Wide Analysis of Inbred Mouse Lines Identifies a Locus Containing Ppar-γ as Contributing to Enhanced Malaria Survival. PLoS ONE. 5(5). e10903–e10903. 21 indexed citations
13.
Suzuki, Oscar, Érika Kague, Hongmin Tu, et al.. (2009). Novel pathogenic mutations and skin biopsy analysis in Knobloch syndrome.. PubMed. 15. 801–9. 24 indexed citations
14.
Errera, Flávia Imbroisi Valle, Luís Henrique Santos Canani, Erika Yeh, et al.. (2008). COL18A1 is highly expressed during human adipocyte differentiation and the SNP c.1136C > T in its "frizzled" motif is associated with obesity in diabetes type 2 patients. Anais da Academia Brasileira de Ciências. 80(1). 167–177. 20 indexed citations
15.
Keren, Boris, Oscar Suzuki, Marion Gérard‐Blanluet, et al.. (2007). CNS malformations in Knobloch syndrome with splice mutation in COL18A1 gene. American Journal of Medical Genetics Part A. 143A(13). 1514–1518. 31 indexed citations
16.
Passos‐Bueno, Maria Rita, Oscar Suzuki, Lucia Armelin‐Correa, et al.. (2006). Mutations in collagen 18A1 (COL18A1) and their relevance to the human phenotype. Anais da Academia Brasileira de Ciências. 78(1). 123–131. 46 indexed citations
17.
Suzuki, Oscar, et al.. (2003). Evidence of neuronal migration disorders in Knobloch syndrome: Clinical and molecular analysis of two novel families. American Journal of Medical Genetics Part A. 119A(1). 15–19. 51 indexed citations
18.
Vainzof, Mariz, Oscar Suzuki, Georgine Faulkner, et al.. (2002). Telethonin protein expression in neuromuscular disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1588(1). 33–40. 41 indexed citations
19.
Suzuki, Oscar, Andréa L. Sertié, Vazken M. Der Kaloustian, et al.. (2002). Molecular Analysis of Collagen XVIII Reveals Novel Mutations, Presence of a Third Isoform, and Possible Genetic Heterogeneity in Knobloch Syndrome. The American Journal of Human Genetics. 71(6). 1320–1329. 106 indexed citations
20.
Moreira, Eloísa S., Tim Wiltshire, Georgine Faulkner, et al.. (2000). Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nature Genetics. 24(2). 163–166. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026